The American Bar Association (ABA) Section of Intellectual Property Law, Section of Science and Technology, and Center for Professional Development will be offering a live webinar and teleconference entitled "Single Claim Restriction Requirements: The Interplay Between 35 USC Section 112 and 35 USC Section 121" on February 5, 2013 from 12:00 - 1:30 pm (Eastern). Keisha Hylton-Rodic of Drinker Biddle & Reath LLP will moderate a panel including Thomas L. Irving of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Orlando Lopez of Burns & Levinson LLP; Daniel M. Sullivan of the U.S. Patent and Trademark Office; and Robert D. Titus of Eli Lilly. The panel will examine the balance between 35 U.S.C. § 112 and 35 U.S.C. § 121, and their interplay in the context of single claim restriction requirements and restriction practice as it relates to Markush claims, as well as address tactics that can be used during prosecution to avoid the pitfall of single claim restrictions in chemical and biotech cases in contravention of current case law on the practice.
The registration fee for the webcast is $95 for members of any of the sections sponsoring the webinar, $99 for government attorneys, $150 for ABA members, and $195 for the general public. Those interested in registering for the webinar, can do so here or by calling 800-285-2221.